ENZO THERAPEUTICS, INC.
31Patents
21Active
31Granted
47Portfolio score
Filing activity: Jun 7, 1995 → Oct 5, 2021 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5958681A | Branch migration of nucleotides | Chemistry; Metallurgy | 61 | Expired |
| US8372888B2 | Sphingosine kinase type 1 inhibitors, compositions and processes for using same | Chemistry; Metallurgy | 22 | Active |
| US8314151B2 | Sphingosine kinase type 1 inhibitors, and processes for using same | Chemistry; Metallurgy | 18 | Active |
| US9388121B2 | Sphingosine kinase type 1 inhibitors | Chemistry; Metallurgy | 14 | Active |
| US7863240B2 | Methods and uses of leptin in hepatocellular carcinoma | Human Necessities | 10 | Active |
| US8969291B2 | Methods for decreasing leptin levels or activity for treating inflammation | Chemistry; Metallurgy | 9 | Active |
| US9974758B2 | Sphingosine kinase type 1 inhibitors and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US6358685B1 | Nucleic acid displacer compositions and cells comprising same | Chemistry; Metallurgy | 5 | Expired |
| US10166204B2 | Sphingosine kinase type 1 inhibitors and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10456370B2 | Sphingosine kinase type 1 inhibitors and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US7494806B1 | Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences | Chemistry; Metallurgy | 2 | Expired |
| US11167011B2 | Methods for treating bone loss using sclerostin peptides | Chemistry; Metallurgy | 1 | Active |
| US8609821B2 | Antibodies against APRIL as biomarkers for early prognosis of lymphoma patients | Chemistry; Metallurgy | 1 | Active |
| US8012456B2 | Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom | Chemistry; Metallurgy | 1 | Expired |
| US8703480B1 | Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells | Chemistry; Metallurgy | 1 | Expired |
| US10723797B2 | Methods for treating psoriasis | Chemistry; Metallurgy | 1 | Active |
| US10328120B2 | Pharmaceutical compositions targeting WNT pathway proteins | Chemistry; Metallurgy | 1 | Active |
| US11737992B2 | Sphingosine kinase Type 1 inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11938167B2 | Pharmaceutical compositions and methods targeting Wnt pathway proteins | Chemistry; Metallurgy | 0 | Active |
| US8592394B2 | Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders | Human Necessities | 0 | Active |
| US8586564B2 | Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders | Human Necessities | 0 | Active |
| US9717754B2 | Glucocerebroside treatment of disease | Human Necessities | 0 | Expired |
| US10639324B2 | Glucocerebroside treatment of disease | Human Necessities | 0 | Active |
| US7439060B1 | Independent helper virus packaging cell line for propagating viral vectors | Chemistry; Metallurgy | 0 | Expired |
| US8367822B2 | Compositions and methods for bone formation and remodeling | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.